LOADING
Comparing Mastercard Inc (MA) and Thermo Fisher Scientific (TMO) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MA | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $433.5B | $176.0B |
| P/E Ratio | 28.4 | 26.0 |
| Forward P/E | 25.0 | 19.0 |
| PEG Ratio | 1.51 | 1.56 |
| EPS | $17.27 | $18.19 |
| Revenue Growth (YoY) | 15.8% | 6.2% |
| Profit Margin | 45.9% | 15.1% |
| Return on Equity | 232.1% | 13.5% |
| Dividend Yield | 0.67% | 0.38% |
| Beta | 0.74 | 0.87 |
| 52-Week High | $599.05 | $642.71 |
| 52-Week Low | $464.52 | $384.06 |
| Volume | -- | -- |
Mastercard Inc is the larger company by market capitalization. Thermo Fisher Scientific trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Mastercard Inc offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.